Outcomes assessed included systolic BP (SBP), diastolic BP (DBP), heart rate (HR), fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), and body mass index (BMI). The gene discussed is INS; the disease is Insulin resistance.